Molecular Templates Interest Expense 2011-2026 | MTEM

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Molecular Templates

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	853 K	431 K	16.8 M	9.34 M	-2.32 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.8 M	-2.32 M	5.01 M

Quarterly Interest Expense Molecular Templates

2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	279 K	98 K	295 K	-	107 K	422 K	223 K	-	-118 K	-996 K	370 K	-	315 K	596 K	-1.57 M	-	-341 K	6.66 M	1.46 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.66 M	-1.57 M	520 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	1.82 M	$ 22.2	-	$ 3.68 B	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Exelixis EXEL	-198 K	$ 44.69	-	$ 12.1 B	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Galapagos NV GLPG	1.03 M	$ 27.86	-	$ 2.69 B	Belgium
Harmony Biosciences Holdings HRMY	-680 K	$ 31.05	-	$ 1.79 B	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
ImmuCell Corporation ICCC	349 K	$ 8.44	-	$ 76.2 M	USA
Brainstorm Cell Therapeutics BCLI	-93 K	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	14.2 M	$ 101.57	-	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Incyte Corporation INCY	25.1 M	$ 99.1	-	$ 19.3 B	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
InMed Pharmaceuticals INM	431 K	$ 0.7	-	$ 1.71 M	Canada
INmune Bio INMB	2.28 M	$ 1.33	-	$ 32.9 M	USA
Innoviva INVA	16.7 M	$ 23.05	-	$ 1.55 B	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	440 K	$ 1.48	-0.67 %	$ 235 M	France
Jaguar Health JAGX	67 K	$ 7.88	-	$ 18.4 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
KalVista Pharmaceuticals KALV	8.56 M	$ 26.67	-	$ 1.44 B	Britain
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 2.98	-	$ 4.91 M	Israel
Krystal Biotech KRYS	1.49 M	$ 259.95	-	$ 7.52 B	USA
Ligand Pharmaceuticals Incorporated LGND	-54.9 M	$ 224.86	-	$ 4.11 B	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Liquidia Corporation LQDA	2.34 M	$ 38.15	-	$ 3.28 B	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
Aquestive Therapeutics AQST	6.55 M	$ 4.05	-	$ 433 M	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA